Based on these results, this study revealed that inhibiting C1QTNF1-AS1 enhances the proliferation, migration, and invasion abilities of osteosarcoma cells by blocking the glycolysis driven by miR-34a-5p. The gene discussed is C1QTNF1; the disease is osteosarcoma.